Atlas Trials

Using Speech to Monitor Symptom Severity in Arabic Speaking Patients With Schizophrenia

Clinical trial NCT05563818 · COMPLETED

Trial details

NCT number
NCT05563818
Sponsor
Hikma Pharmaceuticals LLC
Status
COMPLETED
Study type
OBSERVATIONAL
Schizophrenia
Start date
2021-11-09
Primary completion
2022-12-20
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.